Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4919039 | 5931507 | F | 1 | 4919039-2 | 20060130 | 20060216 | EXP | USA0511112791 | ELI LILLY AND COMPANY | F | N | 20060202 | MD | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4919039 | 1006962200 | PS | CYMBALTA | 1 | 90 MG, DAILY (1/D) | D | D | 21427 |
Indications of drugs used
| no results found |
Outcome of event
| no results found |
Reactions reported
| Event ID | PT |
|---|---|
| 4919039 | ASPARTATE AMINOTRANSFERASE INCREASED |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 4919039 | CR |
| 4919039 | HP |
Therapies reported
| no results found |